<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font17">convalescent </span>
   <span class="font17">plasma </span>
   <span class="font15">for </span>
   <span class="font15">with </span>
   <span class="font14">COVID- </span>
   <span class="font14">patients </span>
   <span class="font13">from </span>
   <span class="font12">April </span>
   <span class="font12">were </span>
   <span class="font12">{background </span>
   <span class="font12">studies </span>
   <span class="font12">been </span>
   <span class="font12">have </span>
   <span class="font12">treatment </span>
   <span class="font11">Studies </span>
   <span class="font11">Convalescent </span>
   <span class="font11">disease </span>
   <span class="font11">margin </span>
   <span class="font11">that </span>
   <span class="font11">The </span>
   <span class="font11">{border-style </span>
   <span class="font11">not </span>
   <span class="font11">px;} </span>
   <span class="font11">severe </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Plasma </span>
   <span class="font11">antibody </span>
   <span class="font11">are </span>
   <span class="font11">days </span>
   <span class="font11">was </span>
   <span class="font11">administration </span>
   <span class="font11">clinical </span>
   <span class="font11">respiratory </span>
   <span class="font11">this </span>
   <span class="font11">virus </span>
   <span class="font11">COVID-. </span>
   <span class="font11">after </span>
   <span class="font11">ahead </span>
   <span class="font11">blood </span>
   <span class="font11">should </span>
   <span class="font11">Table </span>
   <span class="font11">[Epub </span>
   <span class="font11">al. </span>
   <span class="font11">antibodies </span>
   <span class="font11">coronavirus </span>
   <span class="font11">other </span>
   <span class="font11">print]. </span>
   <span class="font11">study </span>
   <span class="font11">transfusion </span>
   <span class="font11">Accessed </span>
   <span class="font11">donors </span>
   <span class="font11">early </span>
   <span class="font11">such </span>
   <span class="font11">therapy </span>
   <span class="font10">also </span>
   <span class="font10">can </span>
   <span class="font10">has </span>
   <span class="font10">viral </span>
   <span class="font10">Patients </span>
   <span class="font10">Registered </span>
   <span class="font10">case </span>
   <span class="font10">neutralizing </span>
   <span class="font10">than </span>
   <span class="font10">(updated </span>
   <span class="font10">Blood </span>
   <span class="font10">Evaluate </span>
   <span class="font10">Immunoglobulin </span>
   <span class="font10">Included. </span>
   <span class="font10">Therapy </span>
   <span class="font10">acute </span>
   <span class="font10">during </span>
   <span class="font10">first </span>
   <span class="font10">may </span>
   <span class="font10">plasma. </span>
   <span class="font10">potential </span>
   <span class="font10">syndrome </span>
   <span class="font10">these </span>
   <span class="font10">time </span>
   <span class="font10">titers </span>
   <span class="font10">(Continued) </span>
   <span class="font10">Chinese </span>
   <span class="font10">Infect </span>
   <span class="font10">but </span>
   <span class="font10">cases </span>
   <span class="font10">could </span>
   <span class="font10">evidence </span>
   <span class="font10">influenza </span>
   <span class="font10">patient </span>
   <span class="font10">provide </span>
   <span class="font10">px; </span>
   <span class="font10">results </span>
   <span class="font10">who </span>
   <span class="font10">{font-family </span>
   <span class="font10">According </span>
   <span class="font10">Clinical </span>
   <span class="font10">European </span>
   <span class="font10">Treatment </span>
   <span class="font10">font-size </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">including </span>
   <span class="font10">more </span>
   <span class="font10">provided </span>
   <span class="font10">risk </span>
   <span class="font10">whereas </span>
   <span class="font10">(NCT) </span>
   <span class="font10">All </span>
   <span class="font10">Ebola </span>
   <span class="font10">Trial </span>
   <span class="font10">administered </span>
   <span class="font10">among </span>
   <span class="font10">between </span>
   <span class="font10">context </span>
   <span class="font10">day </span>
   <span class="font10">donor </span>
   <span class="font10">double; </span>
   <span class="font10">guidance </span>
   <span class="font10">infection </span>
   <span class="font10">namely </span>
   <span class="font10">oxygen </span>
   <span class="font10">patients. </span>
   <span class="font10">plasma, </span>
   <span class="font10">published </span>
   <span class="font10">recovered </span>
   <span class="font10">serious </span>
   <span class="font10">serum </span>
   <span class="font10">studies, </span>
   <span class="font10">titer </span>
   <span class="font10">total </span>
   <span class="font10">transfusion. </span>
   <span class="font10">use </span>
   <span class="font10">where </span>
   <span class="font10">within </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Clin </span>
   <span class="font10">Clinicaltrials.gov, </span>
   <span class="font10">IgG </span>
   <span class="font10">March </span>
   <span class="font10">Society </span>
   <span class="font10">This </span>
   <span class="font10">Withdrawn </span>
   <span class="font10">[], </span>
   <span class="font10">all </span>
   <span class="font10">article </span>
   <span class="font10">beneficial </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">collection </span>
   <span class="font10">evaluation </span>
   <span class="font10">had </span>
   <span class="font10">hyperimmune </span>
   <span class="font10">improvement </span>
   <span class="font10">interval </span>
   <span class="font10">less </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">need </span>
   <span class="font10">non-randomized </span>
   <span class="font10">one </span>
   <span class="font10">positive </span>
   <span class="font10">presented </span>
   <span class="font10">randomized </span>
   <span class="font10">registered </span>
   <span class="font10">research </span>
   <span class="font10">response </span>
   <span class="font10">same </span>
   <span class="font10">selection </span>
   <span class="font10">series </span>
   <span class="font10">solid; </span>
   <span class="font10">symptoms </span>
   <span class="font10">test </span>
   <span class="font10">their </span>
   <span class="font10">under </span>
   <span class="font10">used </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Cancelled </span>
   <span class="font10">Dis.;:â€". </span>
   <span class="font10">Drug </span>
   <span class="font10">East </span>
   <span class="font10">Emerging </span>
   <span class="font10">Health </span>
   <span class="font10">Middle </span>
   <span class="font10">Registry, </span>
   <span class="font10">SARS-CoV- </span>
   <span class="font10">Spanish </span>
   <span class="font10">antibody-dependent </span>
   <span class="font10">any </span>
   <span class="font10">assessment </span>
   <span class="font10">background </span>
   <span class="font10">biochemical </span>
   <span class="font10">bold </span>
   <span class="font10">cases, </span>
   <span class="font10">cases. </span>
   <span class="font10">collected </span>
   <span class="font10">courier; </span>
   <span class="font10">criteria </span>
   <span class="font10">critically </span>
   <span class="font10">data </span>
   <span class="font10">death </span>
   <span class="font10">decrease </span>
   <span class="font10">em; </span>
   <span class="font10">enhancement </span>
   <span class="font10">future </span>
   <span class="font10">identified </span>
   <span class="font10">immune </span>
   <span class="font10">increased </span>
   <span class="font10">infection, </span>
   <span class="font10">later </span>
   <span class="font10">lung </span>
   <span class="font10">majority </span>
   <span class="font10">new </span>
   <span class="font10">noted </span>
   <span class="font10">pertains </span>
   <span class="font10">pneumonia </span>
   <span class="font10">promising </span>
   <span class="font10">pt;} </span>
   <span class="font10">received </span>
   <span class="font10">receiving </span>
   <span class="font10">reduction </span>
   <span class="font10">review </span>
   <span class="font10">showed </span>
   <span class="font10">some </span>
   <span class="font10">trial. </span>
   <span class="font10">trials </span>
   <span class="font10">well </span>
   <span class="font10">will </span>
   <span class="font10">would </span>
  </p>
 </body>
</html>
